Blueberries reduce pro-inflammatory cytokine TNF-α and IL-6 production in mouse macrophages by inhibiting NF-κB activation and the MAPK pathway

Molecular Nutrition and Food Research

Volumn 55, Issue 10, 2011, Pages 1587-1591

  Xie, Chenghui ^a   Kang, Jie ^a   Ferguson, Matthew E ^b   Nagarajan, Shanmugam ^a   Badger, Thomas M ^a   Wu, Xianli ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b U S DEPARTMENT OF AGRICULTURE   (United States)

Author keywords

Blueberry; Cytokine; Inflammation; MAPK; NF B

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BLUEBERRY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; INFLAMMATION; MACROPHAGE; METABOLISM; MOUSE; MOUSE MUTANT; RAT;

ANIMALS; BLUEBERRY PLANT; FEMALE; GENE EXPRESSION REGULATION; INFLAMMATION; INTERLEUKIN-6; MACROPHAGES; MICE; MICE, MUTANT STRAINS; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; RATS; TUMOR NECROSIS FACTOR-ALPHA;

MUS; RATTUS; VACCINIUM;

EID: 80053103611     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201100344     Document Type: Article

References (21)

1. Neto, C. C., Cranberry and blueberry: evidence for protective effects against cancer and vascular diseases. Mol. Nutr. Food Res. 2007, 51, 652-664.
2. Wu, X., Kang, J., Xie, C., Burris, R. et al., Dietary blueberries attenuate atherosclerosis in apolipoprotein E-deficient mice by upregulating antioxidant enzyme expression. J. Nutr. 2010, 140, 1628-1632.
3. Libby, P., Inflammation in atherosclerosis. Nature 2002, 420, 868-874.
4. Szekanecz, Z., Pro-inflammatory cytokines in atherosclerosis. Isr. Med. Assoc. J. 2008, 10, 529-530.
5. Gotsman, I., Stabholz, A., Planer, D., Pugatsch, T. et al., Serum cytokine tumor necrosis factor-alpha and interleukin-6 associated with the severity of coronary artery disease: indicators of an active inflammatory burden? Isr. Med. Assoc. J. 2008, 10, 494-498.
6. Huber, S. A., Sakkinen, P., Conze, D., Hardin, N. et al., Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 1999, 19, 2364-2367.
7. Branen, L., Hovgaard, L., Nitulescu, M., Bengtsson, E. et al., Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler. Thromb. Vasc. Biol. 2004, 24, 2137-2142.
8. Basu, A., Du, M., Leyva, M. J., Sanchez, K. et al., Blueberries decrease cardiovascular risk factors in obese men and women with metabolic syndrome. J. Nutr. 2010, 140, 1582-1587.
9. Zafra-Stone, S., Yasmin, T., Bagchi, M., Chatterjee, A. et al., Berry anthocyanins as novel antioxidants in human health and disease prevention. Mol. Nutr. Food Res. 2007, 51, 675-683.
10. Lau, F., Bielinski, D., Joseph, J., Inhibitory effects of blueberry extract on the production of inflammatory mediators in lipopolysaccharide-activated BV2 microglia. J. Neurosci. Res. 2007, 85, 1010-1017.
11. Lau, F. C., Joseph, J. A., McDonald, J. E., Kalt, W., Attenuation of iNOS and COX2 by blueberry polyphenols is mediated through the suppression of NF-κB activation. J. Funct. Food 2009, 1, 274-283.
12. Chong, M. F., Macdonald, R., Lovegrove, J. A., Fruit polyphenols and CVD risk: a review of human intervention studies. Br. J. Nutr. 2010, 104, S28-S39.
13. Neto, C. C., Cranberry and blueberry: evidence for protective effects against cancer and vascular diseases. Mol. Nutr. Food Res. 2007, 51, 652-664.
14. Manach, C., Williamson, G., Morand, C., Scalbert, A. et al., Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 2005, 81, 230S-242S.
15. Ahmet, I., Spangler, E., Shukitt-Hale, B., Joseph, J. A. et al., Survival and cardioprotective benefits of long-term blueberry enriched diet in dilated cardiomyopathy following myocardial infarction in rats. PLoS One 2009, 4, e7975.
16. Ahmet, I., Spangler, E., Shukitt-Hale, B., Juhaszova, M. et al., Blueberry-enriched diet protects rat heart from ischemic damage. PLoS One 2009, 4, e5954.
17. de Winther, M. P., Kanters, E., Kraal, G., Hofker, M. H., Nuclear factor kappaB signaling in atherogenesis. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 904-914.
18. Muslin, A. J., MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets. Clin. Sci. (London) 2008, 115, 203-218.
19. Xagorari, A., Roussos, C., Papapetropoulos, A., Inhibition of LPS-stimulated pathways in macrophages by the flavonoid luteolin. Br. J. Pharmacol. 2002, 136, 1058-1064.
20. Baeuerle, P. A., Henkel, T., Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 1994, 12, 141-179.
21. Viatour, P., Merville, M. P., Bours, V., Chariot, A., Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem. Sci. 2005, 30, 43-52.